|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Enhancing efficacy of stem cell transplantation to the heart with a PEGylated fibrin biomatrix显示文摘 | Zhang Ge Hu Qing-song Braunlin EA | 2008 | Tissue Eng Part A2008，14，6： | 1 |
| 2 | Interruption of the aortic arch with aorticopulmonary septal defect显示文摘 | Elizabeth Braunlin William M. Peoples Robert M. Freedom Donald C. Fyler Allan Goldblatt Jesse E. Edwards | 1982 | Pediatric Cardiology1982，，4： | 1 |
| 3 | Cardiac disease in patients with nmcopolysaccharidosis: presentation, diagnosis and management 显示文摘 | Braunlin EA Harmatz PR Scarpa M | 2011 | J Inherit Metab Dis2011，34，： | 1 |
| 4 | Usefulness of bone marrow transplantation in the Hurler syndrome 显示文摘 | Braunlin EA Stauffer NR Peters CH | 2003 | Am J Cardiol2003，92，7： | 1 |
| 5 | Interruption of the aortic arch with aorucoulmon-ary septal defect; an anatomic review 显示文摘 | Braunlin E peoples WM Freedom RM | 1982 | Pediatr Cardiol1982，3，： | 1 |
| 6 | Cardiac disease in patients with mucopolysacchari-dosis :presentation, diagnosis and management显示文摘 | BRAUNLIN E A HARMATZ P R SCARPA M etal | 2011 | JInherit Metab Dis2011，34，： | 1 |
| 7 | 显示文摘 | Bailey M J Braunlin W H | 2001 | Macrormoleclues2001，34，6： | 1 |
| 8 | Unexpected coronary artery findings in mucopolysaccharidosis. Report of four cases and literature review显示文摘 | Elizabeth Braunlin Paul J. Orchard Chester B. Whitley Luke Schroeder Robyn C. Reed J. Carlos Manivel | 2014 | Cardiovascular Pathology2014，，： | 1 |
| 9 | Usefulness of bone marrow transplantation in the Hurler syndrome显示文摘 | Braunlin EA Stauffer NR Peters CH | 2003 | Am J Cantiol2003，92，7： | 1 |
| 10 | 黏多糖贮积症I型酶替代治疗后的心脏改变显示文摘Mucopolysaccharidosis type I is a lethal autosomal recessive storage disease caused by a deficiency of lysosomal α-l-iduronidase and the consequent systemic accumulation of glycosaminoglycan. Cardiomyopathy and valvar insufficiency occur as glycosaminoglycan accumulates in the myocardium, expands the spongiosa of cardiac valves, and proliferates within the myointima of the epicardial coronary arteries. Congestive heart failure and death occur within the first decade of life in the most severe cases. Allogeneic hematopoietic stem cell transplantation, used in severe forms of the disease, markedly prolongs survival, alleviates ventricular hypertrophy, and preserves cardiac function, but cardiac valves continue to thicken and valvular insufficiency progresses. Enzyme replacement therapy with human recombinant α-l-iduronidase has been proposed as an alternative therapy for patients with mucopolysaccharidosis type I in whom the risk/benefit ratio of hematopoietic stem cell transplantation seems unfavorable. The investigators report the cardiac findings in a small series of 5 children with mucopolysaccharidosis type I who received enzyme replacement therapy for as long as 7 years. No deaths occurred during treatment. Left ventricular hypertrophy,which was present before therapy, resolved in all cases, and myocardial function remained normal. In contrast, the mitral and aortic valves remained thickened and, in some instances, developed progressive thickening and regurgitation. In conclusion, long-term enzyme replacement therapy has some clear benefits for the myocardium, but the cardiac valves appear unresponsive, and the ultimate effect on the coronary vasculature is unknown. | Braunlin E.A. Berry J.M. Whitley C.B. 雷聪 | 2006 | 世界核心医学期刊文摘(心脏病学分册)2006，，12： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员